Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/03/2023* -- Results Q4 2022 -- 1.89 --
02/03/2023* -- Earnings Call Q4 2022 -- -- --
10/20/2022 -- Results Q3 2022 -- 2.18 --
10/20/2022 08:30 EST Earnings Call Q3 2022 -- -- --
07/21/2022 08:30 EST Earnings Call Q2 2022 -- -- --
07/21/2022 -- Results Q2 2022 2.36 2.27 3.91%
04/21/2022 -- Results Q1 2022 3.22 3.00 7.26%
04/21/2022 08:30 EST Earnings Call Q1 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 02/03/2023 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 10/20/2022
Beat/Miss Upgrade
Return Since 11.73%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
URL https://www.questdiagnostics.com
Investor Relations URL https://ir.questdiagnostics.com/overview/default.aspx
HQ State/Province New Jersey
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Value
Next Earnings Release Feb. 03, 2023 (est.)
Last Earnings Release Oct. 20, 2022
Next Ex-Dividend Date Jan. 17, 2023
Last Ex-Dividend Date Oct. 03, 2022

Dividends

Dividend Per Share (TTM) 2.60
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 1.337
Yield to Sector 1.155
Yield to Industry 5.085
Last Dividend Amt. 0.66
Dividend Frequency Quarterly
Last Ex-Dividend Date Oct. 03, 2022
Yield (TTM) 1.73%
Forward Yield 1.75%
Payout Ratio 24.86%
Cash Payout Ratio 20.97%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
8.35%
31.89%
9.16%
-13.84%
31.15%
14.04%
47.86%
-11.32%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-13.26%
9.26%
11.42%
20.01%
11.80%
49.55%
45.32%
48.57%
-16.42%
14.59%
3.83%
24.25%
-20.78%
33.88%
20.32%
54.36%
-22.44%
--
--
--
--
--
54.43%
18.78%
-31.10%
-58.68%
-88.50%
-99.97%
-99.39%
-89.16%
-15.67%
-56.75%
-61.29%
As of December 02, 2022.

Profile

Edit
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
URL https://www.questdiagnostics.com
Investor Relations URL https://ir.questdiagnostics.com/overview/default.aspx
HQ State/Province New Jersey
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Value
Next Earnings Release Feb. 03, 2023 (est.)
Last Earnings Release Oct. 20, 2022
Next Ex-Dividend Date Jan. 17, 2023
Last Ex-Dividend Date Oct. 03, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
IHF 52.45M USD 3.25%
ATL1364 44.35M USD 2.16%
ACCLX 173.09M USD 2.06%
ALVGX 53.09M USD 1.77%
VEVCX 256.42M USD 1.75%
RYH 16.91M USD 1.74%
FXH 26.49M USD 1.72%
SPGP 25.31M USD 1.51%
SHISX 119.46M USD 1.35%
ZLU.TO 18.03M USD 1.30%
PLASX 46.26M USD 1.27%
FTA 12.00M USD 0.93%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter DGX Tweets